PACS Group CEO Jason Murray sells $2.18m in company stock

Jason Hulse Murray, Co-Founder, CEO, and Chairman of PACS Group, Inc. (NASDAQ:PACS), recently sold common stock totaling $2,177,634 across three separate transactions. The sales occurred between October 19 and October 21, 2026, with the weighted average prices for these sales ranging from $47.5677 to $47.6511 per share. Mr. Murray also serves as a Director and 10% Owner of the company. The timing of these sales comes as PACS stock trades near its 52-week high of $49.49, following a remarkable 274% return over the past year.

On October 19, 2026, Mr. Murray sold 1,620 shares of common stock at a weighted average price of $47.5677 per share. These shares were sold in multiple transactions at prices ranging from $47.50 to $47.99. The following day, October 20, 2026, he disposed of 37,477 shares at a weighted average price of $47.6511, with individual share prices ranging from $47.50 to $47.835. The final reported sale on October 21, 2026, involved 6,610 shares at a weighted average price of $47.618 per share, with prices for these transactions ranging from $47.50 to $47.82.

All sales were executed pursuant to a Rule 10b5-1 trading plan, which Mr. Murray adopted on May 18, 2026. Following these transactions, Mr. Murray directly holds 54,270,813 shares of PACS Group common stock. The company currently carries a market capitalization of $7.56 billion and analysts have set price targets ranging from $57 to $62. According to InvestingPro, which offers 11 additional exclusive tips for PACS, the stock appears slightly overvalued at current levels. Investors seeking deeper insights can access comprehensive analysis through PACS’s Pro Research Report, available for this and 1,400+ other US equities.

In other recent news, PACS Group Inc. announced its financial results, revealing significant developments for investors. The company has entered into agreements to acquire 32 skilled nursing facilities across Florida, marking its expansion into the 21st state. This acquisition is expected to add 4,049 skilled nursing beds, with operations in key areas such as Tampa, St. Petersburg, and Orlando. Truist Securities has reiterated a Buy rating on PACS Group, maintaining a price target of $62.00, following this strategic expansion. Additionally, the company has completed further closings of its Eduro Healthcare transaction, which is part of its ongoing growth strategy.

In leadership news, PACS Group named Patrick J. Murphy as Chief Legal Officer and Corporate Secretary, effective September 21, 2026. Murphy takes over from John Mitchell, who retired but will continue to support the company as a consultant during the transition. These recent developments highlight PACS Group’s strategic moves in both expansion and leadership, providing investors with essential insights into the company’s current trajectory.